Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Vista Gold
VGZ
$363M
| $150K | ﹤0.01% |
+78,533
| New | +$171K |
2026 Q2
0 quarters
|
|
3602
Bally's
BALY
$682M
| $148K | ﹤0.01% |
+10,826
| New | +$138K |
2026 Q2
0 quarters
|
|
3603
KORU Medical Systems
KRMD
$138M
| $148K | ﹤0.01% |
35,336
+9,260
| +36% | +$37.9K |
2025 Q2
4 quarters
|
|
3604
Benitec Biopharma
BNTC
$305M
| $147K | ﹤0.01% |
+10,985
| New | +$130K |
2026 Q2
0 quarters
|
|
3605
Abeona Therapeutics
ABEO
$249M
| $147K | ﹤0.01% |
23,724
+745
| +3% | +$4.09K |
2025 Q2
4 quarters
|
|
3606
SelectQuote
SLQT
$64M
| $146K | ﹤0.01% |
173,563
-107,743
| -38% | -$98.1K |
2020 Q2
24 quarters
|
|
3607
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$247M
| $145K | ﹤0.01% |
11,113
-128
| -1% | -$1.71K |
2025 Q3
3 quarters
|
|
3608
Braemar Hotels & Resorts
BHR
$89.3M
| $145K | ﹤0.01% |
67,282
-6,217
| -8% | -$14.9K |
2016 Q1
41 quarters
|
|
|
NAKA
3609
Nakamoto Inc
NAKA
$105M
| $145K | ﹤0.01% |
36,774
+21,651
| +143% | +$145K |
2025 Q3
3 quarters
|
|
3610
Children's Place
PLCE
$9.34M
| $145K | ﹤0.01% |
47,576
-4,749
| -9% | -$16.1K |
2013 Q2
52 quarters
|
|
|
GPMT
3611
Granite Point Mortgage Trust
GPMT
$20.6M
| $144K | ﹤0.01% |
9,605
-585
| -6% | -$8.4K |
2017 Q4
34 quarters
|
|
3612
Yatsen Holding
YSG
$211M
| $143K | ﹤0.01% |
45,244
-6,280
| -12% | -$19K |
2021 Q2
20 quarters
|
|
3613
CapsoVision Inc
CV
$363M
| $143K | ﹤0.01% |
+18,827
| New | +$127K |
2026 Q2
0 quarters
|
|
3614
Acacia Research
ACTG
$423M
| $142K | ﹤0.01% |
30,527
-46,056
| -60% | -$221K |
2016 Q3
39 quarters
|
|
3615
Twenty One Capital Inc
XXI
$1.9B
| $142K | ﹤0.01% |
28,731
+5,283
| +23% | +$37.1K |
2026 Q1
1 quarter
|
|
3616
Spero Therapeutics
SPRO
$61.7M
| $142K | ﹤0.01% |
64,245
+18,871
| +42% | +$49.4K |
2025 Q2
4 quarters
|
|
3617
Grifois
GRFS
$5.51B
| $142K | ﹤0.01% |
+20,051
| New | +$158K |
2026 Q2
0 quarters
|
|
3618
Medifast
MED
$136M
| $141K | ﹤0.01% |
13,315
-19,461
| -59% | -$224K |
2013 Q2
52 quarters
|
|
3619
DiaMedica Therapeutics
DMAC
$499M
| $139K | ﹤0.01% |
19,704
-5,095
| -21% | -$31.3K |
2025 Q2
4 quarters
|
|
3620
Soluna Holdings
SLNH
$164M
| $138K | ﹤0.01% |
102,217
-14,747
| -13% | -$21.3K |
2026 Q1
1 quarter
|
|
3621
Viant Technology
DSP
$272M
| $138K | ﹤0.01% |
+10,874
| New | +$123K |
2026 Q2
0 quarters
|
|
3622
Pure Cycle
PCYO
$258M
| $138K | ﹤0.01% |
+12,840
| New | +$140K |
2026 Q2
0 quarters
|
|
3623
Huya Inc
HUYA
$454M
| $137K | ﹤0.01% |
59,621
-8,280
| -12% | -$23.5K |
2023 Q3
11 quarters
|
|
3624
Eve Holding
EVEX
$519M
| $137K | ﹤0.01% |
54,562
-58,793
| -52% | -$169K |
2024 Q4
6 quarters
|
|
3625
Aegon
AEG
$11.9B
| $137K | ﹤0.01% |
16,211
+1,990
| +14% | +$16.4K |
2026 Q1
1 quarter
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.